Facebook Linkedin RSS Twitter Youtube
Home 2024

FDA policy

Gene Signature for High-Risk Form of Acute Lymphoblastic Leukemia Identified by CHOP Scientists
Cancer

Gene Signature for High-Risk Form of Acute Lymphoblastic Leukemia Identified by CHOP Scientists

Trump to Nominate Makary for FDA Commissioner
Drug Discovery

Trump to Nominate Makary for FDA Commissioner

StockWatch: Moderna Seeks to Reassure Investors on RFK Jr.
Drug Discovery

StockWatch: Moderna Seeks to Reassure Investors on RFK Jr.

StockWatch: Vaccine, ETF Shares Drop as Trump Chooses RFK Jr. for HHS
Drug Discovery

StockWatch: Vaccine, ETF Shares Drop as Trump Chooses RFK Jr. for HHS

Animal Models and Their Alternatives Share the Preclinical Habitat
Cancer

Animal Models and Their Alternatives Share the Preclinical Habitat

Modeling Clonal Evolution in Hematopoietic Malignancies
Cancer

Modeling Clonal Evolution in Hematopoietic Malignancies

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational
Bioprocessing

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths
Cancer

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths

Multiply Labs and Retro Biosciences Partner on Cell Therapy Manufacturing for Age-Related Diseases
Bioprocessing

Multiply Labs and Retro Biosciences Partner on Cell Therapy Manufacturing for Age-Related Diseases

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress
Genome Editing

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress

123...8Page 1 of 8
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.